CORONA Remedies Limited (BOM:544644)
India · Delayed Price · Currency is INR 2,236.30
+36.15 (1.64%)
At close: Sep 11, 2026
CORONA Remedies Market Cap
CORONA Remedies has a market cap or net worth of 136.76 billion as of September 11, 2026.
Market Cap
136.76B
Enterprise Value
138.12B
Revenue
14.79B
Ranking
n/a
PE Ratio
68.71
Stock Price
2,236.30
ChartMarket Cap Chart
Since December 15, 2025, CORONA Remedies's market cap has increased from 87.97B to 136.76B, an increase of 55.46%. That is a compound annual growth rate of 81.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 136.76B | 61.46% |
| Dec 31, 2025 | 84.70B | -3.72% |
| Dec 15, 2025 | 87.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Granules India | 225.41B |
| Caplin Point Laboratories | 209.39B |
| AstraZeneca Pharma India | 169.63B |
| Jubilant Pharmova | 162.36B |
| Viyash Scientific | 112.28B |
| Procter & Gamble Health | 89.81B |
| Bliss GVS Pharma | 76.78B |
| Sanofi India | 70.93B |